People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RemedyMD, Inc. | — | Other Technology | Seed | $2.0M | $68.7M | 2011 |
| ImmVue Therapeutics Inc. | — | Biotechnology | Pre-Seed | $529K | $3.2M | 2024 |
David Moon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Moon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Travis Smith | 1 | 3 |
| Adam Slovik | 1 | 2 |
| Sandy Der | 1 | 1 |
| Robert Racker | 1 | 1 |
| James Hyde | 1 | 1 |
| Phillip Schauer | 1 | 1 |
| Jayan John Nagendran | 1 | 1 |
| Gary Kennedy | 1 | 1 |
| Joon-Hyung John Kim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.